Overlooked Stock: SYK
Stryker Corp. (SYK) ticked higher after hours after the medical tech company posted an earnings beat. George Tsilis turned to how a rally from this mostly unseen stock reflects the healthcare industry.
Strong Segmental Performance to Drive Stryker's Q4 Earnings?
SYK's fourth-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Stryker: A Cool Name For An Awesome Company, But Is It A Buy Ahead Of Earnings?
Stryker Corporation is a high-quality, innovative medical device company with a strong history of revenue, earnings, and FCF growth, driven by R&D and M&A strategies. Shares are currently expensive with a PEG ratio around 3, but the company's consistent performance and market leadership justify a premium valuation. Stryker's strong company culture, impressive ROIC, and substantial insider ownership indicate a durable competitive advantage and a bright future.
Stryker (SYK) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Beyond analysts' top -and-bottom-line estimates for Stryker (SYK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Stryker Stock Falls Despite the Agreement to Acquire Inari Medical
SYK inks an agreement to acquire Inari Medical at a valuation of approximately $4.9 billion.
Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B
Inari Medical (NARI) stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker (SYK) proved to be true.
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
On Monday, Stryker Corporation SYK agreed to acquire Inari Medical Inc. NARI for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion.
Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal
Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion late Monday. Inari stock catapulted on the news.
Exclusive: Medical device maker Stryker nearing a deal to buy Inari Medical, sources say
Medical-device maker Stryker is in advanced talks to acquire Inari Medical , which makes devices that treat patients with venous diseases, people familiar with the matter told Reuters on Monday.
Here's Why You Should Retain Stryker Stock in Your Portfolio for Now
SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
Stryker Gains 30.2% Year to Date: What's Driving the Stock?
SYK continues to witness growth on the back of a robust product line and strategic acquisitions.
Stryker Stock May Gain From Oculan Lighting Platform's Launch
SYK launches the Oculan Lighting Platform to improve lighting conditions in the operating rooms and allow surgeons to perform with more accuracy.
